Large granular lymphocytosis post allogenic bone marrow transplantation is associated with better outcome - A large retrospective single center analysis
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Large granular lymphocytes (LGL) are seen in patients following allogeneic hematopoietic cell transplantation (Allo-HCT) and it has a confounding impact on patient’s prognosis. We assessed 726 consecutive patients at our institution and looked at the clinical characteristics and outcome of patients developing LGL after Allo-HCT using dual T cell depletion as GVHD prophylaxis. The cumulative incidence of LGL lymphocytosis was 15.4%. Notably, a higher proportion of patients who developed LGL had undergone dual T cell depletion as part of their graft-versus-host disease (GVHD) prophylaxis. LGL lymphocytosis was associated with a favorable outcomes, which included a higher two-year overall survival rate (85.4% compared to 53.1%), a lower incidence of non-relapse mortality (6.4% compared to 28%), improved relapse-free survival (76.3% compared to 48.4%), and enhanced GVHD-free relapse-free survival (71.1% compared to 40.1%) all of which were statistically significant. Multivariable analysis confirmed the positive impact of LGL lymphocytosis on patients’ outcome including survival.
